NKTX - Financial Reports List - Nkarta, Inc. - IntrinsicAlpha

Nkarta, Inc. NKTX

Healthcare - Biotechnology - NASDAQ - US

$ 2.22

2.21 %

$ 158 M

Market Cap

-1.16

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	6.55%	0.84%
Annual Report	FY	10-K	2024-12-31	0.00%	7.41%	2.63%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-10.52%	-15.36%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	24.92%	16.67%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-8.06%	4.52%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	21.76%	10.86%
Annual Report	FY	10-K	2023-12-31	0.00%	1.61%	-10.67%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	2.96%	3.20%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-20.57%	-33.49%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-4.67%	-31.48%

1